Connect Biopharma (CNTB) Short Interest Ratio & Short Volume → Bitcoin Rockets To Record High But Buy THIS Instead (From Paradigm Press) (Ad) Free CNTB Stock Alerts $1.55 -0.18 (-10.40%) (As of 04/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Connect Biopharma Short Interest DataCurrent Short Volume115,500 sharesPrevious Short Volume107,400 sharesChange Vs. Previous Month+7.54%Dollar Volume Sold Short$200,970.00Short Interest Ratio / Days to Cover0.7Last Record DateMarch 31, 2024Outstanding Shares55,072,000 sharesFloat Size53,080,000 sharesShort Percent of Float0.22%Today's Trading Volume78,679 sharesAverage Trading Volume151,878 sharesToday's Volume Vs. Average52% Short Selling Connect Biopharma ? Sign up to receive the latest short interest report for Connect Biopharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCNTB Short Interest Over TimeCNTB Days to Cover Over TimeCNTB Percentage of Float Shorted Over Time Ad Paradigm PressBitcoin Rockets To Record High But Buy THIS InsteadRecently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…>>Click here to find out what it is. Connect Biopharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/2024115,500 shares $200,970.00 +7.5%0.2%0.7 $1.74 3/15/2024107,400 shares $139,620.00 -13.2%0.2%0.8 $1.30 2/29/2024123,700 shares $141,018.00 -2.7%0.2%0.4 $1.14 2/15/2024127,100 shares $153,791.00 -34.8%0.2%0.4 $1.21 1/31/2024194,800 shares $227,916.00 +52.8%0.4%0.5 $1.17 1/15/2024127,500 shares $140,862.00 -21.3%0.2%0.3 $1.10 Get the Latest News and Ratings for CNTB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Connect Biopharma and its competitors with MarketBeat's FREE daily newsletter. 12/31/2023162,100 shares $191,278.00 -59.8%0.3%0.4 $1.18 12/15/2023403,200 shares $380,540.16 +208.3%0.8%1.1 $0.94 11/30/2023130,800 shares $150,420.00 +476.2%0.3%0.6 $1.15 11/15/202322,700 shares $40,406.00 -22.8%0.0%0.1 $1.78 10/31/202329,400 shares $43,218.00 +88.5%0.1%0.5 $1.47 10/15/202315,600 shares $13,543.92 -40.7%0.0%0.3 $0.87 9/30/202326,300 shares $21,539.70 +250.7%0.1%0.6 $0.82 9/15/20237,500 shares $5,700.75 -13.8%0.0%0.2 $0.76 8/31/20238,700 shares $7,184.46 -61.5%0.0%0.2 $0.83 8/15/202322,600 shares $20,358.08 -48.3%0.0%0.1 $0.90 7/31/202343,700 shares $42,389.00 +55.5%0.1%0.1 $0.97 7/15/202328,100 shares $30,348.00 -52.5%0.1%0.1 $1.08 6/30/202359,200 shares $66,896.00 -19.8%0.1%0.2 $1.13 6/15/202373,800 shares $74,538.00 -12.3%0.1%0.2 $1.01 5/31/202384,100 shares $91,147.58 +14.3%0.2%0.1 $1.08 5/15/202373,600 shares $91,256.64 -23.1%0.1%0.2 $1.24 4/30/202395,700 shares $101,920.50 -25.8%0.2%0.3 $1.07 4/15/2023128,900 shares $135,345.00 -14.1%0.2%0.4 $1.05 3/31/2023150,000 shares $149,985.00 +100.8%0.3%0.5 $1.00 3/15/202374,700 shares $83,664.00 -12.2%0.1%0.2 $1.12 2/28/202385,100 shares $109,779.00 -15.0%0.2%1.6 $1.29 2/15/2023100,100 shares $103,103.00 -11.0%0.2%2 $1.03 1/31/2023112,500 shares $138,375.00 -3.5%0.2%2.3 $1.23 1/15/2023116,600 shares $115,317.40 -12.5%0.2%2.3 $0.99 12/30/2022133,200 shares $115,590.96 -58.0%0.3%2.4 $0.87 12/15/2022316,800 shares $275,616.00 -1.2%0.6%2.8 $0.87 11/30/2022320,600 shares $232,531.18 -4.0%0.6%2.8 $0.73 11/15/2022334,000 shares $251,201.40 -8.2%0.6%2.5 $0.75 10/31/2022364,000 shares $316,607.20 -32.0%0.7%2.1 $0.87 10/15/2022535,000 shares $506,003.00 +29.9%1.0%1.7 $0.95 9/30/2022411,900 shares $531,351.00 +2.6%0.8%1.3 $1.29 9/15/2022401,400 shares $586,044.00 -15.7%0.8%1.1 $1.46 8/31/2022476,400 shares $666,960.00 -2.2%0.9%1.2 $1.40 8/15/2022487,100 shares $706,295.00 +1.1%0.9%1.2 $1.45Bitcoin Rockets To Record High But Buy THIS Instead (Ad)Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…>>Click here to find out what it is. CNTB Short Interest - Frequently Asked Questions What is Connect Biopharma's current short interest? Short interest is the volume of Connect Biopharma shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 115,500 shares of CNTB short. 0.22% of Connect Biopharma's shares are currently sold short. Learn More on Connect Biopharma's current short interest. What is a good short interest ratio for Connect Biopharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CNTB shares currently have a short interest ratio of 1.0. Learn More on Connect Biopharma's short interest ratio. Which institutional investors are shorting Connect Biopharma? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Connect Biopharma: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Connect Biopharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.22% of Connect Biopharma's floating shares are currently sold short. Is Connect Biopharma's short interest increasing or decreasing? Connect Biopharma saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 115,500 shares, an increase of 7.5% from the previous total of 107,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Connect Biopharma's float size? Connect Biopharma currently has issued a total of 55,072,000 shares. Some of Connect Biopharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Connect Biopharma currently has a public float of 53,080,000 shares. How does Connect Biopharma's short interest compare to its competitors? 0.22% of Connect Biopharma's shares are currently sold short. Here is how the short interest of companies compare to Connect Biopharma: Milestone Pharmaceuticals Inc. (1.05%), Reviva Pharmaceuticals Holdings, Inc. (3.80%), Genelux Co. (9.50%), Allakos Inc. (6.33%), Seres Therapeutics, Inc. (12.45%), Oramed Pharmaceuticals Inc. (1.44%), DiaMedica Therapeutics Inc. (0.53%), Barinthus Biotherapeutics plc (0.03%), Aclaris Therapeutics, Inc. (6.89%), Anixa Biosciences, Inc. (1.90%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Connect Biopharma stock? Short selling CNTB is an investing strategy that aims to generate trading profit from Connect Biopharma as its price is falling. CNTB shares are trading down $0.18 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Connect Biopharma? A short squeeze for Connect Biopharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CNTB, which in turn drives the price of the stock up even further. How often is Connect Biopharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CNTB, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: MIST Short Interest RVPH Short Interest GNLX Short Interest ALLK Short Interest MCRB Short Interest ORMP Short Interest DMAC Short Interest BRNS Short Interest ACRS Short Interest ANIX Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CNTB) was last updated on 4/17/2024 by MarketBeat.com Staff From Our Partners[Urgent!] Generational Wealth GameplanCrypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe “Perfect Storm” for GoldGold Safe ExchangeThe "Smart Money" Is Ready for May 1st Are You?Stansberry ResearchOptions trading has suddenly become more reliable.Eagle PublishingTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market AlertsYou won't believe what Citigroup just did to it's depositorsAmerican Alternative